SMTL ID : 7l5o.1

Crystal structure of the noncovalently bonded complex of rilzabrutinib with BTK

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.21 Å
Oligo State
monomer
Ligands
1 x R1L: (2E)-2-{(3R)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl}-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile(Non-covalent)
1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
1 x SO4: SULFATE ION(Non-functional Binders)
1 x ACT: ACETATE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Owens, T.D., The Discovery Rilzabrutinib (PRN1008): A Reversible Covalent BTK Inhibitor for Immune Mediated Diseases. To Be Published
Release Date
2022-06-29
Peptides
Tyrosine-protein kinase BTK: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence

5fbn.1 | 5fbn.2 | 5fbo.1 | 5u9d.1 | 5vfi.1 | 6di0.1 | 6di1.1 | 6di3.1 | 6di5.1 | 6di9.1 | 6n9p.1 | 6nfh.1 | 6omu.1 | 6x3n.1 | 6x3o.1 | 6x3o.2 | 6x3p.1 | 7kxm.1 | 7kxp.1 | 7l5p.1 | 7l5p.2 | 7r60.1 | 8e2m.1